期刊文献+

转染和干扰Runx2基因对K7 M2细胞的影响 被引量:1

Effect of Transfection Runx2 and siRNA Runx2 on K7 M2
下载PDF
导出
摘要 目的探讨干扰和转染Runx2基因后对K7M2骨肉瘤细胞体外生物学活性的影响。方法分别将阴性对照质粒、携带Runx2和siRNA Runx2的质粒转染到K7M2细胞中。应用Western blot检测转染和干扰Runx2基因对其蛋白表达的影响,并检测细胞体外的增殖能力(MTT)、侵袭性、迁移性和黏附性的变化,并应用流式细胞仪(FCM)检测相应细胞的凋亡率和细胞周期分布的变化。结果与空白对照组比,转染Runx2和siRunx2组的K7M2细胞中Runx2蛋白表达分别明显增强和减弱,而阴性对照质粒组没有明显改变。转染siRunx2组的细胞,MTT结果显示增殖能力明显下降,迁移性、侵袭性和增殖指数(PI)也明显下降,与空白对照组比差异有统计学意义(P<0.05),黏附性和凋亡率却没有明显变化。转染Runx2组K7M2的细胞增殖能力、迁移性、侵袭性和PI明显增高,与空白对照组比差异有统计学意义(P<0.05),黏附性和凋亡率没有明显变化。阴性对照组和空白对照组比上述指标没有明显改变。结论 Runx2可以促进K7M2细胞增殖,增强细胞的侵袭、迁移能力,其机制可能是和改变细胞周期的分布,使细胞更快的进入G2/M期有关。 Objective To investigate the effect of transfection Runx2 or siRNA Runx2 gene on the in vitro bio-characteristics of K7M2 osteosarcoma cell.Methods Scrambled plasmide,plasmids carrying Runx2 and siRNA Runx2 were transfected into K7M2 cells respectively.Runx2 protein expression after transfecting was detected with Western blot.The proliferation capacity,invasion,migration and adhesiveness were observed.Meanwhile,the apoptosis rate and cell cycle distribution of K7M2 cells in each group were detected using flow cytometry.Results Compared with control,Runx2 protein expression of K7M2 cells in the transfected or intervened Runx2 gene group were increased and reduced respectively.The proliferation capacity,migration,invasion and proliferative index in group transfected by siRNA Runx2 was decreased in comparison with control group,and the difference showed statistical deviation.However,the group transfected Runx2 showed opposite characteristics compared with control group.Neither adhesiveness nor apoptosis rate had obvious change in all three groups.There was no obvious change between the scrambled group and control group.Conclusion Runx2 can increase proliferation capacity,invasion,migration of K7M2.The potential mechanism is that it can change the cell cycle distribution,thus make cell transits to G2/M stage more quickly.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2011年第7期770-773,共4页 Cancer Research on Prevention and Treatment
关键词 RUNX2 K7M2 骨肉瘤 增殖 SIRNA Runx2 K7M2 Osteosarcoma Proliferation siRNA
  • 相关文献

参考文献11

  • 1Galindo M, Pratap J, Young DW, et al. The bone-specific ex- pression of Runx2 oscillates during the cell cycle to support a Gl-related antiproliferative function in osteoblasts[J]. J Biol Chem,2005, 280(21) : 20274-20285.
  • 2Won KY, Park HR, Park YK. Prognostic implication of im- munohistochemical Runx2 expression in osteosarcoma[J]. Tu- mori,2009,95(3) :311-316.
  • 3Pereira BP, Zhou Y, Gupta A, et al. Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic os- teosarcoma cell line (OS1) [J]. J Cell Physiol, 2009, 221 (3) : 778-788.
  • 4Lin L, Lx Chen , Hj Wang,et al. Adenovirus-mediated trans- fer of siRNA against Runx2/Cbfal inhibits the formation of heterotopic ossification in animal model[J]. Biochem Biophys Res Corranun, 2006,349 (2) : 564-572.
  • 5Eliseev RA, Dong YF, Sampson E,et al. Runx2-mediated ac- tivation of the Bax gene increases osteosarcoma cell sensitivity to apoptosis[J].Oncogene,2008,27(25):3605-3614.
  • 6Jitesh P, Jacgue line A, Krystin B,et al. Runx2 in breast and prostate cancer cells, Roles in adhesion, invasion and tumor activity in bone[J]. Proc Am Assoc Cancer Res, 2006, 47: 3971-3975.
  • 7Olfa G, Christophe C, Philippe L,et al. RUNX2 regulates the effects of TNFalpha on proliferation and apoptosis in SaOs-2 cells[J]. Bone, 2010,46 (4) : 901-910.
  • 8Westendorf JJ. Transcriptional co-repressors of Runx2[J]. J Cell Biochem r 2006,98 ( 1 ) : 54-64.
  • 9Nathan SS,Pereira BP, Zhou YF,et al. Elevated expression of Runx2 as a key parameter in the etiology of osteosarcoma[J]. Mol Biol Rep,2009,36(1) : 153-158.
  • 10Qiao M, Shapiro P, Fosbrink M, et al. Cell Cycle-dependent Phosphorylation of the RUNX2 Transcription Factor by cdc2 Regulates Endothelial Cell Proliferation[J].J Biol Chem, 2006, 281(11) :7118-7128.

同被引文献23

  • 1张立智,蔡宣松,钱志康,梅炯,马小辉,黄煌渊,黄伟达.EPHA2-siRNA质粒对骨肉瘤细胞生物学行为的影响[J].中华肿瘤杂志,2007,29(8):566-569. 被引量:6
  • 2VON EISENHART ROTHE R, TOEPFER A, SALZMANN M, et al. Primary malignant bone tumors I J]. Orthopade, 2011, 40 (12) : 1121 -1142.
  • 3INBAR FEIGENBERG M, CHOUFANI S, BUTCHER D T, et al. Basic concepts of epigenetics [ J]. Fertil Steril, 2013, 99 ( 3 ) : 607 -615.
  • 4ELBASHIR S M, HARBORTH J, LENDECKEL W, et al. Duple- xes of 21 - nucleotide RNAs mediate RNA interference in cultured mammalian cells[J]. Nature, 2001, 411 (6836) : 494-498.
  • 5DAI N, ZHONG Z Y, CUN Y P, et al. Alteration of the microRNA expression profile in human osteosarcoma cells transfected with APE1 siRNA[J]. Neoplasma, 2013, 60(4): 384-394.
  • 6ODA Y, YAMAMOTO H, TAMIYA S, et al. CXCR4 and VEGF expression in the primary site and the metastatic site of human os- teosarcoma : analysis within a group of patients, all of whom devel- oped lung metastasis [ J ]. Mod Pathol, 2006, 19 (5) : 738 - 745.
  • 7MEI J, GAO Y, ZHANG L, et al. VEGF - siRNA silencing in- duces apoptosis, inhibits proliferation and suppresses vasculogenic mimicry in osteosarcoma in vitro[ J]. Exp Oncol, 2008, 30( 1 ) : 29 - 34.
  • 8GAO Y S, MEI J, TONG T L, et al. Inhibitory effects of VEGF - siRNA mediated by adenovirus on osteosarcoma - bearing nude mice [ J ]. Cancer Biother Radiopharm, 2009,24 (2) : 243 - 247.
  • 9KtM Y T, ZHAO M. Aberrant cell cycle regulation in cervical car- cinoma[J]. Yonsei Med J, 2005, 46(5) : 597 -613.
  • 10ABD ELRAHMAN I, HERSHKO K, NEUMAN T, et al. The in- hibitor of apoptosis protein Livin (ML- IAP) plays a dual role in tumorigenicity~ J ]. Cancer Res, 2009, 69 (13) : 5475 - 5480.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部